Antibiotics, Antineoplastic
"Antibiotics, Antineoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
| Descriptor ID |
D000903
|
| MeSH Number(s) |
D27.505.954.248.106
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibiotics, Antineoplastic".
Below are MeSH descriptors whose meaning is more specific than "Antibiotics, Antineoplastic".
This graph shows the total number of publications written about "Antibiotics, Antineoplastic" by people in this website by year, and whether "Antibiotics, Antineoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 3 | 3 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2008 | 2 | 3 | 5 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 1 | 4 |
| 2012 | 1 | 2 | 3 |
| 2013 | 2 | 2 | 4 |
| 2014 | 6 | 3 | 9 |
| 2015 | 5 | 3 | 8 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 1 | 4 |
| 2018 | 0 | 2 | 2 |
| 2019 | 4 | 2 | 6 |
| 2020 | 3 | 1 | 4 |
| 2021 | 3 | 2 | 5 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 1 | 1 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibiotics, Antineoplastic" by people in Profiles.
-
Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study. ESC Heart Fail. 2026 May 05; 13(3).
-
A novel murine model of LITT for glioblastoma reveals tumor reduction, BBB permeabilization, and drug delivery via ThermoDox?. Drug Deliv Transl Res. 2026 Aug; 16(8):2911-2920.
-
Sirolimus in the Management of Complex Infantile Hemangiomas: A State-of-the-Art Review. Pediatr Dermatol. 2025 Nov-Dec; 42(6):1126-1132.
-
Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in mice. Brain Behav Immun. 2025 Oct; 129:547-556.
-
Loss of CELF2 promotes skin tumorigenesis and increases drug resistance. Int J Dermatol. 2025 Jan; 64(1):101-110.
-
Guidelines for Standardization of Pediatric Anthracycline Cardiomyopathy Echocardiogram Surveillance-A Call for Harmonization in the Field to Enhance Research in the Cancer Survivor Population. Pediatr Cardiol. 2024 02; 45(2):452-453.
-
Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clin Cancer Res. 2023 11 01; 29(21):4430-4440.
-
Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic?Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023 03; 16(3):269-278.
-
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines. Hematol Oncol. 2022 Oct; 40(4):626-636.
-
Visualizing Ocular Surface Squamous Neoplasia. Ophthalmology. 2022 02; 129(2):146.